Metabolism and pharmacokinetics of MnDPDP in man

References

• Borg D. C., Cotzias G. C. Manganese metabolism in man. Rapid exchange of Mn56 with tissue as demonstrated by blood clearance and liver uptake. J. Clin. Invest. 1958; 37: 1269
   PubMed Web of Science ®Google Scholar
• Davidsson L., Cederblad A., Lonnerdal B., Sandstrom B. Manganese retention in man. A method for estimating manganese absorption in man. Am. J. Clin. Nutr. 1989; 49: 170
   PubMed Web of Science ®Google Scholar
• Dinoto D. R., Kennedy C. D., Johnson J. A., et al. Pharma-cokinetics and biotransformation of the MRI liver contrast agent mangafodipir trisodium injection in normal human male volunteers. 4th Int. ISSX Meeting, Seattle 1995; 8: 323
   Google Scholar
• Elizondo G., Fretz C. J., Stark D. D., et al. Preclinical evaluation of MnDPDP. New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178: 73
   PubMed Web of Science ®Google Scholar
• Gibbons R. A., Dixon S. N., Hallis K., Russell A. M., Sansom B. F., Symonds H. W. Manganese metabolism in cows and goats. Biochim. Biophys. Acta 1976; 444: 1
   PubMed Web of Science ®Google Scholar
• Grant D., Zech K., Holtz E. Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 1994; 29: S249
   PubMed Web of Science ®Google Scholar
• Hustvedt S. O., Grant D., Southon T. E., Zech K. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol. 1997; 38: 690
   PubMed Web of Science ®Google Scholar
• Jynge P., Brurok H., Asplund A., Towart R., Refsum H., Karlsson J. O. G. Cardiovascular safety of MnDPDP and MnCl2. Acta Radiol. 1997; 38: 740
   PubMed Web of Science ®Google Scholar
• Kang Y. S., Gore J. C. Studies of tissue NMR relaxation enhancement by manganese. Dose and time dependences. Invest. Radiol. 1984; 19: 399
   PubMed Web of Science ®Google Scholar
• Larsen L. E., Grant D. General toxicology of MnDPDP. Acta Radiol. 1997; 38: 770
   PubMed Web of Science ®Google Scholar
• Mahoney J. P., Small W. J. Studies on manganese. 3. The biological half-life of radiomanganese in man and factors which affect this half-life. J. Clin. Invest. 1968; 47: 643
   PubMed Web of Science ®Google Scholar
• Ni Y., Petre C., Bosmans H., et al. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2. Acta Radiol. 1997; 38: 700
   PubMed Web of Science ®Google Scholar
• Rocklage S. M., Cacheris W. P., Quay S. C., Hahn F. E., Raymond K. N. Manganese(II) N,N1-dipyridoxylethylene-diamine-N,N1-diacetate 5,51-bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg. Chem. 1989; 28: 477
   Web of Science ®Google Scholar
• Rofsky N. M., Weinreb J. C., Bernardino M. E., Young S. W., Lee J. K., Noz M. E. Hepatocellular tumors. Characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993; 188: 53
   PubMed Web of Science ®Google Scholar
• Rowland M., Tozer T. N. Clinical pharmacokinetics. Concepts and applications, 2nd edn. Lea & Febiger, Philadelphia 1989
   Google Scholar
• Rummeny E. J., Torres C. G., Kurdziel J. C., Nilsen G., Op De Beeck B., Lundby B. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Acta Radiol. 1997; 38: 638
   PubMed Web of Science ®Google Scholar
• Schramm V. L., Brandt M. The manganese(II) economy of rat hepatocytes. Fed. Proc. 1986; 45: 2817
   PubMedGoogle Scholar
• Schroeder H. A., Balassa J. J., Tipton I. H. Essential trace metals in man. Manganese. A study in homeostasis. J. Chronic Dis. 1966; 19: 545
   PubMedGoogle Scholar
• Sherwin P. F., Hugo F. P., Robison R. O., et al. Safety, tolerance, and pharmacokinetics of high doses of gadodiamide injection, a nonionic magnetic resonance contrast agent. Acad. Radiol. 1994; 1: S2
   Google Scholar
• Southon T. E., Grant D., Bjørnerud A., et al. NMR relaxation studies with MnDPDP. Acta Radiol. 1997; 38: 708
   PubMed Web of Science ®Google Scholar
• Spiller M., Brown R. D., Koenig S. H., Wolf G. L. Longitudinal proton relaxation rates in rabbit tissues after intravenous injection of free and chelated Mn2+. Magn. Reson. Med. 1988; 8: 293
   PubMed Web of Science ®Google Scholar
• Tirkkonen B., Aukrust A., Couture E., et al. Physico-chemical characterisation of mangafodipir trisodium. Acta Radiol. 1997; 38: 780
   PubMed Web of Science ®Google Scholar
• Toft K. G., Friisk G. A., Skotland T. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging. Detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography. J. Pharm. Bi-omed. Anal. 1997; 15: 973
   PubMed Web of Science ®Google Scholar
• Toft K. G., Hustvedt S. O., Grant D., Friisk G. A., Skotland T. Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs. Eur. J. Drug Metab. Phar-macokinet. 1997; 22: 65
   PubMed Web of Science ®Google Scholar
• Toft K. G., Kindberg G. M., Skotland T. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging. In vitro metabolism and protein binding studies of the active component MnDPDP in human blood. J. Pharm. Biomed. Anal. 1997; 15: 983
   PubMed Web of Science ®Google Scholar
• Torres C. G., Lundby B., Sterud A. Tufte, McGill S., Gordon P. B., Bjerknes H. Strand. MnDPDP for MR imaging of the liver. Results from the European phase III studies. Acta Radiol. 1997; 38: 631
   PubMed Web of Science ®Google Scholar
• Wang C., Gordon P. B., Hustvedt S. O., et al. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol. 1997; 38: 665
   PubMed Web of Science ®Google Scholar